Cardiff Oncology, Inc. (CRDF) Return On Equity % [USD] 2012 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cardiff Oncology, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Cardiff Oncology, Inc. Return On Equity for the quarter ending March 31, 2024 was -54.5 %, a 52.9% decline year-over-year.
  • Cardiff Oncology, Inc. annual Return On Equity for 2023 was -50.1 %, a 52.2% decline from 2022.
  • Cardiff Oncology, Inc. annual Return On Equity for 2022 was -32.9 %, a 56.4% decline from 2021.
  • Cardiff Oncology, Inc. annual Return On Equity for 2021 was -21.1 %, a 47.6% increase from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -54.5 -18.9 -52.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -50.1 -17.2 -52.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -44.4 -13.1 -42% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.4 -10.6 -36.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.7 -10.6 -42% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.9 -11.9 -56.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -31.3 -11.9 -61.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.8 -7.16 -33.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -25.1 +1.12 +4.27% Jan 1, 2022 Mar 31, 2022
Q4 2021 -21.1 +19.1 +47.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -19.4 +75.7 +79.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -21.7 +128 +85.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -26.2 +203 +88.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -40.2 +162 +80.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -95 +90.2 +48.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -149 +0.63 +0.42% Apr 1, 2020 Jun 30, 2020
Q1 2020 -229 -108 -88.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -202 -59.6 -41.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -185 -45.7 -32.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -150 +39 +20.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -122 +301 +71.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -142 +262 +64.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -140 +186 +57.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -189 +53.4 +22.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -423 -249 -144% Jan 1, 2018 Mar 31, 2018
Q4 2017 -404 -274 -210% Oct 1, 2017 Dec 31, 2017
Q3 2017 -326 -224 -220% Jul 1, 2017 Sep 30, 2017
Q2 2017 -242 -173 -251% Apr 1, 2017 Jun 30, 2017
Q1 2017 -173 -98.4 -131% Jan 1, 2017 Mar 31, 2017
Q4 2016 -130 -54.7 -72.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -102 -7.5 -7.94% Jul 1, 2016 Sep 30, 2016
Q2 2016 -69 +107 +60.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -75.1 +43.8 +36.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -75.7 +27.1 +26.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -94.5 -31.6 -50.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -176 -125 -247% Apr 1, 2015 Jun 30, 2015
Q1 2015 -119 -21.1 -21.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -103 +13.7 +11.7% Oct 1, 2014 Dec 31, 2014
Q3 2014 -62.9 +243 +79.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -50.6 +810 +94.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -97.8 +227 +69.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -116 +441 +79.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -306 +1.06 K +77.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -861 Apr 1, 2013 Jun 30, 2013
Q1 2013 -325 Jan 1, 2013 Mar 31, 2013
Q4 2012 -557 Oct 1, 2012 Dec 31, 2012
Q3 2012 -1.37 K Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.